Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide.

Fabiana GregucciAlessia SurgoIlaria BonaparteLetizia LaeraMaria Paola CilibertiRoberta CarbonaraMaria Annunziata GentileDavid GiraldiRoberto CalbiMorena CaliandroNicola SassoSalvatore D'OriaCarlo SommaGaetano MartinelliGiammarco SuricoGiuseppe Lombardi Alba Fiorentino

Published in: Journal of personalized medicine (2021)

SIB-hypo-RT associated with TMZ in poor-prognosis patients affected by GBM is an effective and safe treatment. Prospective studies could be warranted.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
early stage
radiation therapy
small cell lung cancer
squamous cell carcinoma
patient reported outcomes
rectal cancer
replacement therapy